RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 211.7 USD | -0.31% |
|
+0.39% | +23.08% |
| Jun. 11 | Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing | MT |
| May. 23 | ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea | MT |
ETFs positioned on ResMed, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 6 M€ | +17.98% | - | |
| 0.10% | 133 M€ | +10.01% | - | |
| 0.09% | 2,567 M€ | +17.37% | - | |
| 0.09% | 61 M€ | +26.95% | - | |
| 0.08% | 1 M€ | +0.04% | ||
| 0.08% | 273 M€ | -.--% | ||
| 0.08% | 655 M€ | -.--% | - | |
| 0.08% | 1,174 M€ | +23.54% | ||
| 0.07% | 248 M€ | +14.27% | - | |
| 0.07% | 379 M€ | +8.50% | ||
| 0.07% | 288 M€ | +24.16% | ||
| 0.07% | 14 M€ | +16.19% | - | |
| 0.06% | 0 M€ | 0.00% | - | |
| 0.06% | 1 M€ | -.--% | ||
| 0.06% | 284 M€ | -.--% | ||
| 0.06% | 560 M€ | +10.19% | - | |
| 0.06% | 35 M€ | +16.68% | - | |
| 0.05% | 23 M€ | -.--% | - | |
| 0.05% | 786 M€ | -.--% | ||
| 0.05% | 206 M€ | -.--% | ||
| 0.05% | 36 M€ | +9.69% | - | |
| 0.05% | 205 M€ | -.--% | ||
| 0.04% | 414 M€ | +11.31% | - | |
| 0.04% | 607 M€ | +0.05% | - | |
| 0.04% | 1,166 M€ | +0.26% | - | |
| 0.04% | 324 M€ | +7.90% | - | |
| 0.04% | 40 M€ | +6.61% | - |
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-07-31
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
211.7
USD
Average target price
218.7
USD
Spread / Average Target
+3.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.08% | 31.1B | |
| +7.77% | 218B | |
| +10.16% | 189B | |
| +26.21% | 151B | |
| +32.78% | 113B | |
| +1.98% | 64.02B | |
| +14.48% | 52.6B | |
| +2.92% | 49.85B | |
| -6.60% | 37.89B | |
| -1.07% | 34.92B |
- Stock Market
- Equities
- RMD Stock
- Funds and ETFs ResMed, Inc.
